Medicines shouldn’t be a luxury Take action!

WHO Executive Board's Special Session on Ebola

Events |

29 January 2019

MSF statements at WHO Executive Board 144th session

UN Photo/Christopher Black

Thumbnail

MSF representatives are attending the 144^th session of the WHO executive board meetings and will be speaking on a number of topics.

Our statements

Statement |

31 January 2019

Drug-resistant infections

144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance

2 min

Statement |

29 January 2019

Research and development

144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines

2 min

Statement |

29 January 2019

Research and development

144th WHO EB: Medicines, vaccines and health products: Cancer medicines

2 min

Statement |

30 January 2019

144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis

2 min

Read, watch, share

Statement |

03 February 2020

Tropical & neglected diseases

WHO 146th EB -13 (EB146/14) – Neglected tropical diseases

2 min

Statement |

18 January 2021

Diabetes

MSF Statement on EB148/6 – Non communicable diseases

2 min

Statement |

18 January 2021

Tropical & neglected diseases

MSF Statement on EB148/6 – Oral health and noma disease

2 min

Statement |

18 January 2021

Intellectual property and trade

MSF Statement on EB148/8 – Global strategy and plan of action on public health, innovation and intellectual property (GSPOA)

2 min